[HTML][HTML] Assessment of salivary opiorphin in oral lichen planus
Z Dalirsani, M Amirchaghmaghi, A Ghazi… - Brazilian Journal of …, 2024 - SciELO Brasil
Opiorphin is a pentapeptide, which could be isolated from human fluids and has a
decreasing effect on pain. Aim Since lichen planus is a chronic mucocutaneous disease …
decreasing effect on pain. Aim Since lichen planus is a chronic mucocutaneous disease …
[PDF][PDF] Quantitative analysis and expression of salivary opiorphin in painful oral soft-tissue conditions: A descriptive study
NK Nejad, KA RP, S Sujatha - J Global Oral Health, 2020 - researchgate.net
Objectives: Opiorphin is an enkephalinase inhibitor which suppresses pain by acting on the
opioid system. The levels of opiorphin in plasma and saliva have shown to vary in patients …
opioid system. The levels of opiorphin in plasma and saliva have shown to vary in patients …
Salivary Opiorphin is Dependent of Pain Intensity in Chronic TMD Patients
Objectives Opiorphin is pentapeptide that inhibits pain perception in humans. It can be
isolated from body fluids, including saliva. The cause of temporomandibular disorders …
isolated from body fluids, including saliva. The cause of temporomandibular disorders …
Salivary opiorphin in dental pain: A potential biomarker for dental disease
MS Ozdogan, M Gungormus, SI Yusufoglu… - Archives of Oral …, 2019 - Elsevier
Objectives Opiorphin is a recently discovered peptide shown to inhibit the enkephalin-
degrading enzymes and prolong the effects of enkephalins. Although opiorphin is found in …
degrading enzymes and prolong the effects of enkephalins. Although opiorphin is found in …
Opiorphin as a biomarker of orofacial conditions: a meta-analysis
AL Porporatti, CA de Oliveira Machado, I Alajbeg… - Scientific reports, 2023 - nature.com
The aim of this meta-analysis was to answer the following question:“Are there any
differences in opiorphin biomarker concentrations between different orofacial conditions and …
differences in opiorphin biomarker concentrations between different orofacial conditions and …
Opiorphin in burning mouth syndrome patients: a case-control study
Objectives Opiorphin is a pentapeptide isolated from human saliva that suppresses pain
from chemically induced inflammation and acute physical pain. Burning mouth syndrome …
from chemically induced inflammation and acute physical pain. Burning mouth syndrome …
Opiorphin Level in Unstimulated Whole Saliva of Burning Mouth Syndrome Patients.
J TP - Journal of the medical association of Thailand, 2019 - search.ebscohost.com
Background: Burning mouth syndrome (BMS) is characterized by intense burning sensation
of the tongue or other regions of the oral mucosa with no known medical or dental cause …
of the tongue or other regions of the oral mucosa with no known medical or dental cause …
Salivary opiorphin levels in denture‐related traumatic ulcers
MS Ozdogan, M Gungormus - Oral Diseases, 2023 - Wiley Online Library
Objective Opiorphin is a pentapeptide secreted in saliva and has a strong analgesic effect.
Salivary opiorphin has been shown to increase in orofacial pain and may act as a pain …
Salivary opiorphin has been shown to increase in orofacial pain and may act as a pain …
A study of salivary opiorphin levels using different anesthetic drugs and techniques–A randomized controlled clinical study
SK Parida, T Guruprasad, VB Krishnakumar… - Journal of stomatology …, 2018 - Elsevier
Purpose This study aimed at assessing the change in salivary opiorphin levels before and
after administration of local anesthesia, with the use of three different local anesthetic …
after administration of local anesthesia, with the use of three different local anesthetic …
Evaluation of Salivary Opiorphin, pH and Flow Rate in Oral Submucous Fibrosis-A Case-Control Observational Study
KS Varsha, KC Lakshmi, A Ganesan… - Journal of Pharmacy …, 2023 - journals.lww.com
Aim and Objectives: The aim of the study was to evaluate the salivary pH, flow rate and
opiorphin in Oral submucous fibrosis patients and to compare them with healthy individuals …
opiorphin in Oral submucous fibrosis patients and to compare them with healthy individuals …